Dentsply Sirona Inc (XRAY) Cash Flow Statement
A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide.
Total Cash From Operating Activities Chart for Dentsply Sirona Inc
Dentsply Sirona Inc (XRAY) operating cash flow for FY2025 was USD 235.0M, a -49.0% change from FY2024. Dentsply Sirona Inc's operating cash flow grew from USD 2.6M in 1989 to USD 235.0M in 2025 (8938.5% over 36 years). Operating cash flow compound annual growth rate: 5-year CAGR of -18.0%, 10-year CAGR of -7.2%, 20-year CAGR of 0.0%.
Total Cash From Operating Activities (US Dollars)
R&D as % of Revenue
Key Stats
- Market Cap
- $1.70B
- Implied Share Price
- $8.52
- Enterprise Value
- $4.02B
- Revenue (TTM)
- $3.64B
- EBITDA
- $526.00M
- Profit Margin
- -14.99%
- Trailing P/E
- —
- Forward P/E
- 6.33
- Price/Book (MRQ)
- 1.44
- Price/Sales (TTM)
- 0.47
- EV/EBITDA
- 43.25
- EV/Revenue
- 1.10
- Dividend Yield
- 3.74%
- Book Value
- $6.58
- Free Cash Flow (FY2025)
- $104.00M
- Free Cash Flow Yield
- 6.12%
Snapshot as of 7th October 2026 — not point-in-time controlled, may lag the live market by a few days.